Literature DB >> 24523606

Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.

E Polat1, U Duman2, M Duman1, A E Atici1, E Reyhan1, T Dalgic3, E B Bostanci3, S Yol1.   

Abstract

BACKGROUND: Since the first introduction of tumour markers, their usefulness for diagnosis has been a challenging question. The aim of the present prospective study was to investigate, in colorectal cancer patients, the relationship between preoperative tumour marker concentrations and various clinical variables.
METHODS: The study prospectively enrolled 131 consecutive patients with a confirmed diagnosis of colorectal carcinoma and 131 age- and sex-matched control subjects with no malignancy. The relationships of the tumour markers carcinoembryonic antigen (cea) and carbohydrate antigen (ca) 19-9 with disease stage, tumour differentiation (grade), mucus production, liver function tests, T stage, N stage, M stage were investigated.
RESULTS: Serum concentrations of cea were significantly higher in the patient group than in the control group (p = 0.001); they were also significantly higher in stage iii (p = 0.018) and iv disease (p = 0.001) than in stage i. Serum concentrations of cea were significantly elevated in the presence of spread to lymph nodes (p = 0.005) in the patient group. Levels of both tumour markers were significantly elevated in the presence of distant metastasis in the patient group (p = 0.005 for cea; p = 0.004 for ca 19-9).
CONCLUSIONS: Preoperative levels of cea and ca 19-9 might provide an estimate of lymph node invasion and distant metastasis in colorectal cancer patients.

Entities:  

Keywords:  Carbohydrate antigen 19-9; carcinoembryonic antigen; colorectal cancer

Year:  2014        PMID: 24523606      PMCID: PMC3921033          DOI: 10.3747/co.21.1711

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  39 in total

1.  Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.

Authors:  L E Harrison; J G Guillem; P Paty; A M Cohen
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

Review 2.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.

Authors:  S Hammarström
Journal:  Semin Cancer Biol       Date:  1999-04       Impact factor: 15.707

3.  Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer.

Authors:  Murat Basbug; Zulfu Arikanoglu; Nurullah Bulbuller; Ziya Cetinkaya; Erhan Aygen; Sami Akbulut; Omer Satici
Journal:  Hepatogastroenterology       Date:  2011 Mar-Apr

4.  A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

Authors:  H J Kim; M H Kim; S J Myung; B C Lim; E T Park; K S Yoo; D W Seo; S K Lee; Y I Min
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

5.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

6.  The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

Authors:  C G Moertel; J R O'Fallon; V L Go; M J O'Connell; G S Thynne
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

7.  Tumor markers in staging and prognosis of colorectal carcinoma.

Authors:  M Levy; V Visokai; L Lipska; O Topolcan
Journal:  Neoplasma       Date:  2008       Impact factor: 2.575

Review 8.  Carcinoembryonic antigen.

Authors:  R H Fletcher
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

9.  Prospective investigation of tumor markers and risk assessment in early cancer screening.

Authors:  T Kobayashi; T Kawakubo
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

Review 10.  The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer.

Authors:  Walter E Longo; Frank E Johnson
Journal:  Surg Clin North Am       Date:  2002-10       Impact factor: 2.741

View more
  18 in total

1.  The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.

Authors:  Wang-Yang Chen; Xiao-Juan Zhao; Zhi-Fu Yu; Fu-Lan Hu; Yu-Peng Liu; Bin-Bin Cui; Xin-Shu Dong; Ya-Shuang Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  [C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer].

Authors:  Ying-Ying Chen; Jia-He Zhang; Wan Zhang; Zi-Ke Yang; Rong-Cheng Luo; Shi-Jun Kang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

3.  Esophageal cancer management: preoperative CA19.9 and CEA serum levels may identify occult advanced adenocarcinoma.

Authors:  Marco Scarpa; Giulia Noaro; Luca Saadeh; Francesco Cavallin; Matteo Cagol; Rita Alfieri; Mario Plebani; Carlo Castoro
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

4.  Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.

Authors:  Jingtao Wang; Xiao Wang; Fudong Yu; Jian Chen; Senlin Zhao; Dongyuan Zhang; Yang Yu; Xisheng Liu; Huamei Tang; Zhihai Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Development of a novel biomarker model for predicting preoperative lymph node metastatic extent in esophageal squamous cell carcinoma1.

Authors:  Zhao Ma; Xianxian Wu; Bo Xu; Hongjing Jiang; Peng Tang; Jie Yue; Mingquan Ma; Chuangui Chen; Hongdian Zhang; Zhentao Yu
Journal:  Oncotarget       Date:  2017-11-11

6.  Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.

Authors:  Zhan Yu; Zhen Chen; Jian Wu; Zhong Li; Yugang Wu
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

7.  Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).

Authors:  Wei Wu; Zhenzhen Zhang; Xian Hua Gao; Zhen Shen; Yan Jing; Haibo Lu; Heng Li; Xiaoye Yang; Xiangbin Cui; Yuqing Li; Zheng Lou; Peng Liu; Cun Zhang; Wei Zhang
Journal:  Oncotarget       Date:  2017-03-28

8.  HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study.

Authors:  Jun Lu; Hongtao Wang; Xueli Zhang; Xuemei Yu
Journal:  Diabetes Ther       Date:  2018-01-04       Impact factor: 2.945

9.  Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells.

Authors:  Reinhild Holmer; Georg H Wätzig; Sanjay Tiwari; Stefan Rose-John; Holger Kalthoff
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

10.  Elevated Level of Serum Carcinoembryonic Antigen (CEA) and Search for a Malignancy: A Case Report.

Authors:  Fnu Asad-Ur-Rahman; Muhammad W Saif
Journal:  Cureus       Date:  2016-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.